Anzeige der Dokumente 21-27 von 27

    • Prevalence of Hemorrhagic Complications in Hospitalized Patients with Pulmonary Embolism 

      Pagkratis N., Matsagas M., Malli F., Gourgoulianis K.I., Kotsiou O.S. (2022)
      Background: The prevalence of anticoagulant therapy-associated hemorrhagic complications in hospitalized patients with pulmonary embolism (PE) has been scarcely investigated. Aim: To evaluate the prevalence of hemorrhages ...
    • The prognostic utility of ICH-score in anticoagulant related intracerebral hemorrhage 

      Katsanos A.H., Krogias C., Lioutas V.-A., Goyal N., Zand R., Sharma V.K., Varelas P., Malhotra K., Paciaroni M., Sharaf A., Chang J., Karapanayiotides T., Kargiotis O., Pappa A., Mai J., Tsantes A., Boviatsis E., Lambadiari V., Shoamanesh A., Mitsias P.D., Selim M.H., Alexandrov A.V., Tsivgoulis G. (2020)
      Although intracerebral hemorrhage (ICH) score is used to provide an estimate on the probability of mortality following spontaneous ICH of any cause, its utility has not been exclusively tested in ICH patients with history ...
    • Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis 

      Ntaios G., Papavasileiou V., Makaritsis K., Vemmos K., Michel P., Lip G.Y.H. (2017)
      Background and Purpose - Evidence from the real-world setting complements evidence coming from randomized controlled trials. We aimed to summarize all available evidence from high-quality real-world observational studies ...
    • Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study 

      Paciaroni M., Caso V., Agnelli G., Mosconi M.G., Giustozzi M., Seiffge D.J., Engelter S.T., Lyrer P., Polymeris A.A., Kriemler L., Zietz A., Putaala J., Strbian D., Tomppo L., Michel P., Strambo D., Salerno A., Remillard S., Buehrer M., Bavaud O., Vanacker P., Zuurbier S., Yperzeele L., Loos C.M.J., Cappellari M., Emiliani A., Zedde M., Abdul-Rahim A., Dawson J., Cronshaw R., Schirinzi E., Del Sette M., Stretz C., Kala N., Reznik M., Schomer A., Grory B.M., Jayaraman M., Mctaggart R., Yaghi S., Furie K.L., Masotti L., Grifoni E., Toni D., Risitano A., Falcou A., Petraglia L., Lotti E.M., Padroni M., Pavolucci L., Lochner P., Silvestrelli G., Ciccone A., Alberti A., Venti M., Traballi L., Urbini C., Kargiotis O., Rocco A., Diomedi M., Marcheselli S., Caliandro P., Zauli A., Reale G., Antonenko K., Rota E., Tassinari T., Saia V., Palmerini F., Aridon P., Arnao V., Monaco S., Cottone S., Baldi A., D'Amore C., Ageno W., Pegoraro S., Ntaios G., Sagris D., Giannopoulos S., Kosmidou M., Ntais E., Romoli M., Pantoni L., Rosa S., Bertora P., Chiti A., Canavero I., Saggese C.E., Plocco M., Giorli E., Palaiodimou L., Bakola E., Tsivgoulis G., Bandini F., Gasparro A., Terruso V., Mannino M., Pezzini A., Ornello R., Sacco S., Popovic N., Scoditti U., Genovese A., Denti L., Flomin Y., Mancuso M., Ferrari E., Caselli M.C., Ulivi L., Giannini N., De Marchis G.M. (2022)
      BACKGROUND: In patients with atrial fibrillation who suffered an ischemic stroke while on treatment with nonvitamin K antagonist oral anticoagulants, rates and determinants of recurrent ischemic events and major bleedings ...
    • Review and update of the concept of embolic stroke of undetermined source 

      Diener H.-C., Easton J.D., Hart R.G., Kasner S., Kamel H., Ntaios G. (2022)
      Ischaemic strokes have traditionally been classified according to the TOAST criteria, in which strokes with unclear aetiology are classified as cryptogenic strokes. However, the definition of cryptogenic stroke did not ...
    • Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion 

      Diener H.C., Bernstein R., Butcher K., Campbell B., Cloud G., Davalos A., Davis S., Ferro J.M., Grond M., Krieger D., Ntaios G., Slowik A., Touzé E. (2017)
      Systemic thrombolysis with rt-PA is contraindicated in patients with acute ischemic stroke anticoagulated with dabigatran. This expert opinion provides guidance on the use of the specific reversal agent idarucizumab followed ...
    • Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes 

      Paciaroni M., Agnelli G., Giustozzi M., Tsivgoulis G., Yaghi S., Grory B.M., Furie K.L., Tadi P., Zedde M., Abdul-Rahim A.H., Dawson J., Lees K.R., Alberti A., Venti M., Acciarresi M., D’Amore C., Mosconi M.G., Bogini V., Cappellari M., Rigatelli A., Bonetti B., Putaala J., Tomppo L., Tatlisumak T., Bandini F., Marcheselli S., Pezzini A., Poli L., Padovani A., Masotti L., Grifoni E., Vannucchi V., Sohn S.-I., Lorenzini G., Tassi R., Guideri F., Acampa M., Martini G., Ntaios G., Athanasakis G., Makaritsis K., Karagkiozi E., Vadikolias K., Liantinioti C., Palaiodimou L., Mumoli N., Porta C., Galati F., Sacco S., Tiseo C., Corea F., Ageno W., Bellesini M., Silvestrelli G., Ciccone A., Scoditti U., Denti L., Mancuso M., Caselli M.C., Maccarrone M., Ulivi L., Orlandi G., Giannini N., Tassinari T., Lodovici M.L.D., Rueckert C., Baldi A., Toni D., Gentile L., Letteri F., Giuntini M., Lotti E.M., Flomin Y., Pieroni A., Kargiotis O., Karapanayiotides T., Monaco S., Mannino M., Baronello M.M., Csiba L., Szabó L., Chiti A., Giorli E., Sette M.D., Schirinzi E., Imberti D., Zabzuni D., Doronin B., Volodina V., Michel P., Eskandari A., Vanacker P., Barlinn K., Barlinn J., Deleu D., Gourbali V., Caso V. (2020)
      Introduction: The aim of this study in patients with acute posterior ischaemic stroke (PS) and atrial fibrillation (AF) was to evaluate (1) the risks of recurrent ischaemic event and severe bleeding and (2) these risks in ...